In-silico investigations of novel tacrine derivatives potency against Alzheimer's disease
Tacrine was originally used as a palliative treatment for Alzheimer's disease (AD). But early applications soon revealed a number of its side effects on human health. That's why we decided to examine the effectiveness of novel tacrine derivatives known for their potent inhibition of GluN2B...
Main Authors: | Mohamed El fadili, Mohammed Er-rajy, Mohnad Abdalla, Hatem A. Abuelizz, Sara Zarougui, Fadwa Mohammed Alkhulaifi, Nada F Alahmady, Ashwag Shami, Menana Elhallaoui |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2024-03-01
|
Series: | Scientific African |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468227623005021 |
Similar Items
-
QSAR, ADME-Tox, molecular docking and molecular dynamics simulations of novel selective glycine transporter type 1 inhibitors with memory enhancing properties
by: Mohamed El fadili, et al.
Published: (2023-02-01) -
In-silico screening based on molecular simulations of 3,4-disubstituted pyrrolidine sulfonamides as selective and competitive GlyT1 inhibitors
by: Mohamed El fadili, et al.
Published: (2023-10-01) -
Design of novel anti-cancer agents targeting COX-2 inhibitors based on computational studies
by: Mohammed Er-rajy, et al.
Published: (2023-10-01) -
QSAR, ADMET In Silico Pharmacokinetics, Molecular Docking and Molecular Dynamics Studies of Novel Bicyclo (Aryl Methyl) Benzamides as Potent GlyT1 Inhibitors for the Treatment of Schizophrenia
by: Mohamed El fadili, et al.
Published: (2022-05-01) -
QSAR, DFT studies, docking molecular and simulation dynamic molecular of 2-styrylquinoline derivatives through their anticancer activity
by: Sara Zarougui, et al.
Published: (2023-11-01)